GWM
BNGO icon

Geneos Wealth Management’s Bionano Genomics BNGO Stock Holding History

Geneos Wealth Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed -$2K – 2772
2021
Q3 		$2K Hold
1
– – ﹤0.01% 2630
2021
Q2 		$2K Hold
1
– – ﹤0.01% 2637
2021
Q1 		$2K Hold
1
– – ﹤0.01% 2864
2020
Q4 		$3K Buy
+1
New +$374 ﹤0.01% 2602

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Geneos Wealth Management's BNGO Position: Q4 2021 in Review

Geneos Wealth Management sold out of Bionano Genomics (BNGO) in Q4 2021, closing a stake of 1 share — an estimated $2K sold.

Geneos Wealth Management first reported a position in BNGO in Q4 2020 and held it in 4 quarters. The position peaked at $3K in Q4 2020. 149 funds tracked by Wall St. Rank hold BNGO as of Q4 2021.

  • Geneos Wealth Management reported no remaining Bionano Genomics position as of Q4 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 1 Bionano Genomics share in Q4 2021, an estimated $2K.
  • Geneos Wealth Management first reported a position in Bionano Genomics in Q4 2020 and held it in 4 quarters.
  • Geneos Wealth Management's Bionano Genomics position peaked at $3K in Q4 2020.
  • 149 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2021.

Based on Geneos Wealth Management's 13F filing for Q4 2021, filed 9 Feb 2022.